Rhonda Hoffman joins Bactolife™ as Board Member
We are delighted to introduce Rhonda Hoffman as our newest addition to the Board of Directors Rhonda is a distinguished and seasoned C-suite leader within the nutrition industry, with a long track record from prominent industry organizations in the food ingredient space, including Pharmavite, Abbott Laboratories, Vrios, and P&G. With a breadth of experience that […]
Novozymes and Bactolife join forces to significantly reduce post weaning diarrhea and antibiotic use among weaner pigs
The two companies have signed a joint development and commercialization agreement to launch feed additive Ablacto+. The game changing biosolution uses binding proteins to stabilize the gut of piglets, thereby reducing the need for antibiotic consumption. Copenhagen, Denmark – 4 September 2023. Novozymes and the Danish industrial biotech company, Bactolife, have signed a joint development […]
Bactolife Raises EUR 30 million in Series A Financing
COPENHAGEN, Denmark, 08 August, 2023 – Bactolife A/S (“Bactolife”), a bioindustrial company developing proprietary Binding ProteinsTM, which strengthen the gut microbiome of humans and animals with the aim of reducing the burden of gastrointestinal infections and anti-microbial resistance, today announced that it has successfully raised EUR >30 million since its April 2021 seed round. The […]
Bactolife appoints Jens Møller Nielsen as COO
Bactolife A/S is pleased to welcome Jens Møller Nielsen who takes up the position as COO as of 1 March 2023. Jens joins Bactolife to further strengthen the management and operations teams. He brings solid international management experience within upscaling and production most recently from Coloplast and Topsoe and prior to those 19 years with […]
Bactolife appoints Sebastian Søderberg new CEO
Copenhagen, 4 January 2023: Bactolife announced today that Sebastian Søderberg has been appointed new CEO of the Bactolife as part of a planned succession. Sebastian is an experienced leader and entrepreneur within bio-industrial business and innovation. He will succeed Co-founder Mads Laustsen, who assumes the role as Strategic Advisor to Bactolife. In addition to the CEO […]
Bactolife™ receives a grant for the further development of Binding Proteins™
Bactolife’s Binding Proteins™ reduce the risk of gastrointestinal infections and can benefit people – especially mothers and children – around the world. We are thrilled to continue our journey with the Bill & Melinda Gates Foundation, that has now committed a grant of USDm 2 towards the development of this novel solution. Children’s diarrhea is […]
Lorraine Allen joins Bactolife™ as Commercial Advisor
We are very happy to announce that Lorraine Allen is joining Bactolife as Commercial Advisor. Lorraine has 20+ years’ experience in innovation & brand creation, product launches across multiple markets, brand growth, and business expansion. She worked in the UK market for 10 years with Nestlé in commercial retail, marketing and innovation roles and managed […]
Bactolife™ receives USD 5 million in new funding to address gastrointestinal infections worldwide
The Bill & Melinda Gates Foundation is investing to accelerate Bactolife™’s mission of developing effective and affordable food and feed ingredients to combat some of the largest gut health issues worldwide. COPENHAGEN, Denmark, 30 August 2022 – Bactolife™ today announced that the Bill & Melinda Gates Foundation has committed, in alignment with the foundation’s charitable […]
Thomas Schäfer joins Bactolife™ as Scientific Advisor
We are proud to announce that Thomas Schäfer is joining Bactolife™ as Scientific Advisor. Thomas holds a PhD in Microbiology, Physiology and Biochemistry, and has a rich background within biotech innovation, microbial discovery and development, and leadership from his roles in Novozymes and Chr. Hansen. Latest he served as CSO at Chr. Hansen before stepping […]
Eat your intestines strong
Simple supplement to reduce the risk of gastrointestinal infections from coli bacteria. In addition to saving people from unpleasant experiences, supplements can be used in the fight against diarrhea, which is globally one of the most common causes of infant death. The Innovation Fund invests DKK 11 million in the ColiShield™
